Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs Neostigmine for Postoperative Recovery in Patients After COVID-19
NCT05817019Phase 4Unknown
- Sponsor
- Korea University Ansan Hospital
- Start
- Apr 2023
- Primary completion
- Dec 2024
- Modality
- Biodegradable Polymers, Small Molecules
01
Overview
A Phase 4 trial of Sugammadex in neuromuscular blockade (NMB), postoperative urinary retention (POUR), sponsored by Korea University Ansan Hospital. Status: unknown.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)postoperative urinary retention (POUR)
Beyond the preview
Go deeper on NCT05817019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05817019.